PTC Therapeutics Inc (NASDAQ: PTCT) stock enjoyed a major increase of 21.2% on 5/20/24. The shares closed at $40.12. Moreover, this advance was accompanied by exceptionally high trading volume at 326% of normal. Relative to the market the stock has been strong over the last nine months and has risen 24.4% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be below the cost of capital, PTCT is expected to be a major Value Eraser.
PTC Therapeutics is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment